Expanding the Molecular Language of Protein Liquid-liquid Phase Separation
Authors
Affiliations
Understanding the relationship between a polypeptide sequence and its phase separation has important implications for analysing cellular function, treating disease and designing novel biomaterials. Several sequence features have been identified as drivers for protein liquid-liquid phase separation (LLPS), schematized as a 'molecular grammar' for LLPS. Here we further probe how sequence modulates phase separation and the material properties of the resulting condensates, targeting sequence features previously overlooked in the literature. We generate sequence variants of a repeat polypeptide with either no charged residues, high net charge, no glycine residues or devoid of aromatic or arginine residues. All but one of 12 variants exhibited LLPS, albeit to different extents, despite substantial differences in composition. Furthermore, we find that all the condensates formed behaved like viscous fluids, despite large differences in their viscosities. Our results support the model of multiple interactions between diverse residue pairs-not just a handful of residues-working in tandem to drive the phase separation and dynamics of condensates.
Spontaneous Self-Organized Order Emerging From Intrinsically Disordered Protein Polymers.
Acosta S, Rodriguez-Alonso P, Chaskovska V, Fernandez-Fernandez J, Rodriguez-Cabello J Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2025; 17(1):e70003.
PMID: 39950263 PMC: 11826379. DOI: 10.1002/wnan.70003.
Decoding biomolecular condensate dynamics: an energy landscape approach.
Biswas S, Potoyan D PLoS Comput Biol. 2025; 21(2):e1012826.
PMID: 39928699 PMC: 11841893. DOI: 10.1371/journal.pcbi.1012826.
Expanding the molecular grammar of polar residues and arginine in FUS phase separation.
Wake N, Weng S, Zheng T, Wang S, Kirilenko V, Mittal J Nat Chem Biol. 2025; .
PMID: 39920231 DOI: 10.1038/s41589-024-01828-6.
Molecular determinants of condensate composition.
Holehouse A, Alberti S Mol Cell. 2025; 85(2):290-308.
PMID: 39824169 PMC: 11750178. DOI: 10.1016/j.molcel.2024.12.021.
Biophysical Analysis of Therapeutic Antibodies in the Early Development Pipeline.
Willis L, Kapur N, Radford S, Brockwell D Biologics. 2024; 18:413-432.
PMID: 39723199 PMC: 11669289. DOI: 10.2147/BTT.S486345.